Overview

GABA-glutamate Interactions and Psychosis

Status:
Active, not recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

This study investigates the interactions between NMDA (N-Methyl-D-aspartic acid) antagonism and GABA (gamma-aminobutyric acid) system as it relates to cognitive function assessed by ERPs (event-related potentials) in healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Yale University

Collaborator:

National Alliance for Research on Schizophrenia and Depression

Treatments:

Flumazenil